Glaukos (NYSE:GKOS) Price Target Raised to $110.00

Glaukos (NYSE:GKOS – Free Report) had its price target upped by JPMorgan Chase & Co. from $108.00 to $110.00 in a research report report published on Thursday, Benzinga reports. JPMorgan Chase & Co. currently has an overweight rating on the medical instruments supplier’s stock. Several other research firms also recently commented on GKOS. Citigroup boosted […]

Related Keywords

Canada ,Alexr Thurman ,Gilberth Kliman , ,Allspring Global Investments Holdings ,Needham Company ,Glaukos Company Profile ,Jpmorgan Chase Co ,Wells Fargo Company ,Securities Exchange Commission ,Quadrant Capital Group ,Glaukos Corporation ,Citigroup ,National Bank ,Caldwell Sutter Capital Inc ,Free Report ,Truist Financial ,Wells Fargo ,Moderate Buy ,Get Free Report ,Director Gilbert ,Exchange Commission ,Capital Group ,Global Investments Holdings ,Caldwell Sutter Capital ,Sutter Capital ,Glaukos Daily ,